New Inotropic Drugs for Heart Failure

This publication has 16 references indexed in Scilit:

• Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction.
  Heart, 1985
• Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.
  Proceedings of the National Academy of Sciences, 1985
• Increase in Ca++ sensitivity of myocardial contractile structures by DPI 201-106.
  Journal of Molecular and Cellular Cardiology, 1984
• Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.
  Circulation, 1984
• The new inotropic phosphodiesterase inhibitors
  Archives Internationales de Physiologie et de Biochimie, 1984
• Effects of a cardioselective beta1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction
  The American Journal of Cardiology, 1983
• Pharmacological actions of various inotropic agents
  European Heart Journal, 1983
• Phosphorylation of the Sarcoplasmic Reticulum and Sarcolemma
  Annual Review of Physiology, 1982
• Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist Pirbuterol
  New England Journal of Medicine, 1981
• Hemodynamic effects of intravenous prenalterol in severe heart failure
  The American Journal of Cardiology, 1981